Skip to main content
Fig. 2 | Infectious Agents and Cancer

Fig. 2

From: Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma

Fig. 2

The prognostic predictive value of MFN2 in HCC. Kaplan-Meier analysis revealed that patients with low expression of MFN2 had significantly worse outcomes in terms of overall survival (P = 0.027, a). Compared with the patients with high MFN2 expression, patients with low MFN2 expression had a significantly worse disease-free survival (P = 0.047, b)

Back to article page